Zymeworks Inc (ZYME)

Zymeworks (ZYME) Stock Price & Analysis


ZYME Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.86 - $10.80
Previous Close$6.4
Average Volume (3M)482.37K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$340.09M
Total Debt (Recent Filing)$27.13M
Price to Earnings (P/E)2.3
Nov 07, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.80
Shares Outstanding67,826,689
10 Day Avg. Volume296,530
30 Day Avg. Volume482,373
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)1.23
Price to Sales (P/S)61.99
Price to Cash Flow (P/CF)-19.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside25.00% Upside
Rating ConsensusHold
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Zymeworks Inc’s price range in the past 12 months?
Zymeworks Inc lowest stock price was $4.86 and its highest was $10.80 in the past 12 months.
    What is Zymeworks Inc’s market cap?
    Currently, no data Available
    When is Zymeworks Inc’s upcoming earnings report date?
    Zymeworks Inc’s upcoming earnings report date is Nov 07, 2023 which is in 43 days.
      How were Zymeworks Inc’s earnings last quarter?
      Zymeworks Inc released its earnings results on Aug 10, 2023. The company reported -$0.76 earnings per share for the quarter, missing the consensus estimate of -$0.47 by -$0.29.
        Is Zymeworks Inc overvalued?
        According to Wall Street analysts Zymeworks Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Zymeworks Inc pay dividends?
          Zymeworks Inc does not currently pay dividends.
          What is Zymeworks Inc’s EPS estimate?
          Zymeworks Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Zymeworks Inc have?
          Zymeworks Inc has 67,826,690 shares outstanding.
            What happened to Zymeworks Inc’s price movement after its last earnings report?
            Zymeworks Inc reported an EPS of -$0.76 in its last earnings report, missing expectations of -$0.47. Following the earnings report the stock price went down -7.603%.
              Which hedge fund is a major shareholder of Zymeworks Inc?
              Among the largest hedge funds holding Zymeworks Inc’s share is Perceptive Advisors LLC. It holds Zymeworks Inc’s shares valued at 21M.


                Zymeworks Stock Smart Score

                The Zymeworks stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Zymeworks Inc

                Zymeworks, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.


                Top 5 ETFs holding ZYME

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                Picton Mahoney Fortified Market Neutral Alternative Fund ETF
                Picton Mahoney Fortified Long Short Alternative Fund Trust Units
                Vanguard U.S. Momentum Factor ETF
                Vanguard Russell 3000 ETF
                Up to five ETFs with an Outperform Smart Score that hold ZYME. The ETFs are listed according to market value of ZYME within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Zynerba Pharmaceuticals
                Crispr Therapeutics AG

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis